Analysts expect over 2018 rising revenue Abbott

Tomorrow the American Abbott will publish its past quarter's figures. Over the current book year the total revenue will be 30,85 billion USD (consensus estimates). This is quite more than 2016's revenue of 27,39 billion USD.

Historical revenues and results Abbott plus estimates 2018

fundamental research

The analysts expect for 2018 a net profit of 5,04 billion USD. Most of the analysts anticipate on a profit per share of 2,86 USD. So the price/earnings-ratio equals 20,72.

Per share the analysts are expecting a dividend of 1,12 USD per share. The dividend yield is then 1,89 percent. The average dividend yield of the pharmaceutical companies equals a poor 1 percent.

Based on the current number of shares Abbott 's market capitalization equals 87,3 billion USD.

On Sunday the stock closed at 59,27 USD.

Historical stock prices Abbott

fundamental research abbott

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.